Fortress Biotech - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) closed at $14.84 on November 6, 2026, down 1.3% from the previous close, on volume of 11,699 shares (30-day average 16,145).
Data as of November 6, 2026.
No headlines found.
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 8-Sep 8:00 AM ET)
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock trades on the NASDAQ stock market under the symbol FBIOP.
As of November 6, 2026, FBIOP stock price declined to $14.84 with 11,699 million shares trading.
FBIOP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, FBIOP traded as high as $21.43 and as low as $4.72.
FBIOP has outperformed the market in the last year with a return of +116.6%, while the SPY ETF gained +9.6%. However, in the most recent history, FBIOP shares have underperformed the stock market with its stock returning -22.6% in the last 3 month period and -11.0% for the last 2 week period, while SPY has returned -4.2% and -3.8%, respectively.
FBIOP support price is $14.51 and resistance is $15.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBIOP shares will trade within this expected range on the day.
